Skip to main content

The effect of isoniazid use for tuberculosis prevention on pregnancy incidence among women living with HIV on antiretroviral treatment and progestin-based hormonal contraception

Publication ,  Conference
Diepstra, K; Westreich, D; Bula, A; Lemani, C; Chapola, J; Winston, J; Mollan, K; Hagey, J; Phiri, S; Chiwoko, J; Hosseinipour, M; Cottrell, M ...

Duke Scholars

Location

Halifax, Nova Scotia

Conference Name

ISPE’s 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Diepstra, K., Westreich, D., Bula, A., Lemani, C., Chapola, J., Winston, J., … Tang, J. (n.d.). The effect of isoniazid use for tuberculosis prevention on pregnancy incidence among women living with HIV on antiretroviral treatment and progestin-based hormonal contraception. Presented at the ISPE’s 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Halifax, Nova Scotia.
Diepstra, Karen, Daniel Westreich, Agatha Bula, Clara Lemani, John Chapola, Jennifer Winston, Katie Mollan, et al. “The effect of isoniazid use for tuberculosis prevention on pregnancy incidence among women living with HIV on antiretroviral treatment and progestin-based hormonal contraception,” n.d.
Diepstra K, Westreich D, Bula A, Lemani C, Chapola J, Winston J, Mollan K, Hagey J, Phiri S, Chiwoko J, Hosseinipour M, Cottrell M, Pettifor A, Wood M, Tang J. The effect of isoniazid use for tuberculosis prevention on pregnancy incidence among women living with HIV on antiretroviral treatment and progestin-based hormonal contraception.

Location

Halifax, Nova Scotia

Conference Name

ISPE’s 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management